Quantcast
Last updated on April 16, 2014 at 11:32 EDT

Latest Simvastatin Stories

2014-03-30 08:20:05

Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday THOUSAND OAKS, Calif., March 30, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new detailed data from two Phase 3 pivotal studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant...

2014-03-25 23:02:29

Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina. (PRWEB) March 25, 2014 The law firm McSweeney / Langevin continues to advise women regarding potential legal claims regarding a possible link between use of Lipitor and the development of type 2 diabetes. Recently, federal litigation involving Pfizer, and plaintiffs alleging Lipitor caused type 2 diabetes, was centralized in South Carolina following...

Multiple Sclerosis May Benefit From Statins
2014-03-19 10:09:06

Brett Smith for redOrbit.com - Your Universe Online At first, multiple sclerosis is recognized by sporadic neurological symptoms – a condition called relapsing-remitting MS. Within a decade or so, greater than 50 percent of patients acquire secondary progressive MS, a continuous deterioration of symptoms and boost in disability. Currently, there are no approved drugs for treating this later stage of the disease. However, a newly published study in the UK medical journal The Lancet has...

2014-03-11 08:29:53

Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 /PRNewswire/ -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced that it has secured $45 million in Series B financing. New Enterprise Associates (NEA) led the financing,...

2014-02-19 23:27:12

AlignLife provides a free webinar to educate on Cholesterol and the risk of statin medications. (PRWEB) February 19, 2014 This Thursday, February 20th at 7pm EST, AlignLife clinics will be hosting a free webinar to educate the community about the dangers of statin medications and a natural approach to the management of cholesterol. An interesting study published in The Lancet looked at the incidence of heart disease in 52 countries and revealed that over 90% of heart disease is...

Statins Negatively Interact With Other Meds
2013-11-25 16:05:06

Brett Smith for redOrbit.com - Your Universe Online A new study from a team of American researchers published in the Journal of Clinical Lipidology has found undesirable drug interactions with statins are causing many to discontinue using the cholesterol-lowering drugs. Many drugs are known to add to a common side effect of taking statins – muscle pain. The pain often pushes patients to discontinue using the lifesaving, cholesterol-lowering drugs. While these undesirable...

2013-10-04 23:21:56

d’Oliveira & Associates has posted a new infographic which provides a list of side effects and timeline of events. The law firm works with some of the more experienced Zocor lawyers who handle these cases. (PRWEB) October 04, 2013 Zocor (simvastatin) helps control high cholesterol when combined with a healthy diet and exercise. The FDA approved this medicine in December 1991. It has also been approved in combination with drugs like Januvia (Juvisync) and Zetia (Vytorin). On March...

2013-09-11 23:04:57

Baron and Budd reports on study alleging that Lipitor use may cause a significantly increased risk of type 2 diabetes compared to other drugs in its class LOS ANGELES (PRWEB) September 11, 2013 A study published on May 23, 2013 in the British Medical Journal alleges that many high-potency statins such as Lipitor may increase the risk of developing type 2 diabetes. Statins are commonly used to lower cholesterol and reduce the risk of cardiovascular disease; however the study suggests a...

2013-09-04 08:14:56

In a randomized trial that included about 2,000 patients with or at high risk of cardiovascular disease (CVD), use of a fixed-dose combination medication for blood pressure, cholesterol, and platelet control compared to usual care resulted in significantly improved medication adherence after 15 months and small improvements in systolic blood pressure and low-density lipoprotein cholesterol, according to a study in the September 4 issue of JAMA. "The long-term use of cardiovascular disease...

2013-09-02 09:53:11

Dr Gitt said: "There are wide variations between European countries in the achievement of LDL-cholesterol (LDL-C) targets. However the effect of different reimbursement systems on meeting the targets was unknown." Between June 2008 and February 2009 DYSIS assessed the prevalence and types of persistent lipid abnormalities in patients receiving statins. Eligible patients were at high risk of a cardiovascular event, aged >45 years, and had been on chronic statin treatment for at least...